Dr. Sean Dooley briefs reporters at Walter Reed National Military Medical Center in Bethesda, Md. on Saturday. Trump was admitted to the hospital after contracting the coronavirus. Susan Walsh/AP hide caption toggle caption Susan Walsh/AP Dr. Sean Dooley briefs reporters at Walter Reed National Military Medical Center in Bethesda, Md. on Saturday. Trump was admitted to the hospital after contracting the coronavirus. Susan Walsh/AP President Trump, hospitalized at Walter Reed National Military Medical Center in Maryland, is being treated with remdesivir, an antiviral drug made by Gilead Sciences. While the drug hasn’t been approved by the Food and Drug Administration, it […]
Remdesivir
20 posts
3 Oct, 2020 03:51 Follow RT on US President Donald Trump has begun taking an antiviral therapy after testing positive for the coronavirus, his doctor said, noting that he is responding well so far and does not require supplemental oxygen to aid his breathing. “This afternoon, in consultation with specialists from Walter Reed and Johns Hopkins University, I recommended movement of the president up to Walter Reed National Military Medical Center for further monitoring,” wrote Sean Conley, the president’s physician. I am very happy to report that the president is doing very well. He is not requiring any supplemental oxygen, but in […]
Gilead Remdesivir can Now Be Bought Directly From the Company Supply of our investigational COVID-19 treatment is now meeting demand in the U.S. Today, Gilead has assumed responsibility for U.S. distribution of the drug. Read more: https://t.co/MtZVLkL3SH — Gilead Sciences (@GileadSciences) October 1, 2020 Health Editor’s Note: Gilead is able to keep production of remdesivir (veklury) up and is meeting demand for this antiviral in the U.S. Remdesivir is currently authorized for Temporary use under an Emergency Use Authorization (EUA) for treatment of COVID-19 patients in the hospital, moderate to severe disease, regardless of the need for supplemental oxygen. “Veklury has […]
www.youtube.com Remdesivir Received EUA for Use in Patients with Moderate COVID-19 Gilead announced the @US_FDA expanded the Emergency Use Authorization of our investigational antiviral to now also include hospitalized patients with COVID-19 not requiring oxygen supplementation: https://t.co/J4WzqE2wJu. — Gilead Sciences (@GileadSciences) August 29, 2020 Health Editor’s Note: The antiviral, Remdesivir, Veklury© is now approved for use in the treatment of COVID-19 for all hospitalized patients. A phase 3 trial and an additional NIAID trial have been completed which evaluated remdesivir for use in hospitalized patients with moderate COVID-19 pneumonia. This FDA approval will allow for earlier treatment of patients with COVID-19….Carol […]
The experimental antiviral drug remdesivir shortened hospital stays for seriously ill COVID-19 patients in a federally funded study. But there’s not enough of the medicine to go around. Ulrich Perrey/Pool/AFP via Getty Images hide caption toggle caption Ulrich Perrey/Pool/AFP via Getty Images The experimental antiviral drug remdesivir shortened hospital stays for seriously ill COVID-19 patients in a federally funded study. But there’s not enough of the medicine to go around. Ulrich Perrey/Pool/AFP via Getty Images By the second week in July, COVID-19 cases in North Carolina were climbing fast. With nearly 19,000 diagnoses over the previous two weeks, only five states […]
American biopharmaceutical company Gilead Sciences on Friday announced that recent analysis of its antiviral drug remdesivir reduced the risk of death for severely ill COVID-19 patients by 62% compared with standard care alone. According to a July 10 news release, the analysis, which will be presented at the Virtual COVID-19 Conference on July 10 and 11, suggests remdesivir is linked to a “significantly improved clinical recovery” in very sick COVID-19 patients. The study was based on 312 patients enrolled in a phase three trial. The patients’ results were compared to those of 818 patients in a “real-world retrospective cohort” who had […]
By William Petri, The Conversation I am a physician and a scientist at the University of Virginia. I care for patients and conduct research to find better ways to diagnose and treat infectious diseases, including COVID-19. Here I’m sharing what is known about which treatments work, and which don’t, for the new coronavirus infection. Keep in mind that this field of medicine is rapidly evolving as our understanding of the SARS-CoV-2 virus improves. So what I am writing today may change within days or weeks. Below are the treatments that have been tried and for which we have the best knowledge. […]
Remdesivir, an antiviral drug produced by the California-based Gilead Sciences biopharmaceutical company, has become the first treatment for COVID-19 to receive the backing of the European Medicines Agency and at the same time the bone of contention between the EU and the US after the latter allegedly bought up the global supply of the drug. The European Commission on Friday authorised the use of Remdesivir to treat coronavirus. “Today’s authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus,” EU Health Commissioner Stella Kyriakides said in a statement. Stefan de Keersmaecker, a […]
BRUSSELS (Sputnik) – The European Commission is negotiating with the US-based Gilead Sciences company, which is producing the Remdesivir antiviral drug used against COVID-19, the possibility of providing the EU with a sufficient number of doses of the drug in light of reports that the US intends to stockpile the doses, the official statement said. “Commissioner [Stella] Kyriakides has had multiple discussions with different pharmaceutical companies, including with Gilead, to discuss, for instance, production capacities. Now, at our level, the commission is currently negotiating with Gilead the possibility to reserve … the sufficient quantities doses [of Remdesivir} for the [EU] member […]
Gilead Sciences, maker of the antiviral drug remdesivir, has come up with a price for the COVID-19 treatment that was less than some analysts expected. ULRICH PERREY/POOL/AFP via Getty Images hide caption toggle caption ULRICH PERREY/POOL/AFP via Getty Images Gilead Sciences, maker of the antiviral drug remdesivir, has come up with a price for the COVID-19 treatment that was less than some analysts expected. ULRICH PERREY/POOL/AFP via Getty Images The drugmaker behind the experimental COVID-19 treatment remdesivir has announced how much it will charge for the drug, after months of speculation as the company tried to figure out how to balance […]
Health Editor’s Note: Currently the antiviral remdesivir is being given by intravenous infusions to COVID-19 patients and has been shown to shorten the time to recovery. Gilead has been given the go ahead to work on an inhaled version which will be far easier to give to a patient. An inhaled version would allow for dosing outside a hospital atmosphere and also for earlier treatment…..Carol Gilead is about to start trials of an inhaled version of remdesivir by Open Letter from Daniel O’Day, Chairman and CEO, Gilead Sciences After receiving the green light from the FDA to move forward, Gilead is […]
A researcher at the German Center for Immunity Therapy holds a bag containing blood plasma from a recovered COVID-19 patient at the University Hospital Erlangen on April 27, 2020 in Erlangen, Germany. This plasma could be used to treat people with COVID-19. Alexander Hassenstein/Getty Images hide caption toggle caption Alexander Hassenstein/Getty Images A researcher at the German Center for Immunity Therapy holds a bag containing blood plasma from a recovered COVID-19 patient at the University Hospital Erlangen on April 27, 2020 in Erlangen, Germany. This plasma could be used to treat people with COVID-19. Alexander Hassenstein/Getty Images Right now, there is […]
The US government’s supply of the only proven Covid-19 drug runs out at the end of the month By Elizabeth Cohen and Arman Azad/CNN (CNN)The US government’s current supply of remdesivir, the only drug known to work against Covid-19, will run out at the end of the month, Dr. Robert Kadlec, a US Department of Health and Human Services official, told CNN. The government’s last shipment of the drug will go out the week of June 29. Gilead Sciences, the company that makes the drug, is ramping up to make more, but it’s unclear how much will be available this summer. “Right […]
Colorized scanning electron micrograph of a cell (pink), isolated from a patient sample, that’s heavily infected with SARS-COV-2 virus particles (green).NIAID Early results show benefit of remdesivir for COVID-19 NIH Research Matters At a Glance Early results showed that remdesivir benefited hospitalized patients with severe COVID-19 who required supplemental oxygen. While the findings support remdesivir as a standard therapy for such patients, they suggest more research is needed to improve outcomes for people with COVID-19. Coronaviruses are a large family of viruses that usually cause mild to moderate upper-respiratory tract illnesses like the common cold. SARS-CoV-2, the virus that causes coronavirus […]
Colorized scanning electron micrograph of an apoptotic cell (pink) heavily infected with SARS-COV-2 virus particles (green), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. NIAID Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery NIH News Release The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in the New England Journal of Medicine. The preliminary analysis is based on data from the Adaptive COVID-19 Treatment Trial (ACTT), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National […]
Gilead Science’s remdesivir is one of the most highly anticipated drugs being tested against the new coronavirus. The drug showed positive results in a large-scale U.S. government trial, the company said on April 29. Josh Edelson/AFP via Getty Images hide caption toggle caption Josh Edelson/AFP via Getty Images Gilead Science’s remdesivir is one of the most highly anticipated drugs being tested against the new coronavirus. The drug showed positive results in a large-scale U.S. government trial, the company said on April 29. Josh Edelson/AFP via Getty Images On this broadcast of The National Conversation, we answer your questions about the drug […]
Stoppers are placed on filled vials of the experimental drug remdesivir at a Gilead Sciences factory. Gilead Sciences/AP hide caption toggle caption Gilead Sciences/AP Stoppers are placed on filled vials of the experimental drug remdesivir at a Gilead Sciences factory. Gilead Sciences/AP States are beginning to receive cases of an experimental COVID-19 drug that the Food and Drug Administration authorized for emergency use on May 1. But the distribution process so far has puzzled some hospitals and states about why they’ve been left empty-handed. Gilead Sciences, maker of remdesivir, said it would donate its initial supply of the medicine. The federal […]
The First Case of COVID-19 in the US Treated with Remdesivir Was in late January – Two Weeks Later China Was Mass Producing the Drug – The Firm Gilead Sciences and Dr. Fauci Are In the Middle Tap here to add The Western Journal to your home screen. Source link
This scanning electron microscope image shows SARS-CoV-2 (round blue objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S. Image captured and colorized at NIAID’s Rocky Mountain Laboratories (RML) in Hamilton, Montana.NIAID Health Editor’s Note: COVID-19 is likely to respond to a cocktail of antivirals and anti-inflammatory drugs. The antiviral, Remdesivir has been shown to decrease recovery time in patients with COVID-19. The drug chosen to be used with Remdesivir is Baricitinib (Olumiant) which is a proven anti-inflammatory […]
This scanning electron microscope image shows SARS-CoV-2 (round blue objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S. Image captured and colorized at NIAID’s Rocky Mountain Laboratories (RML) in Hamilton, Montana.NIAID Health Editor’s Note: COVID-19 is likely to respond to a cocktail of antivirals and anti-inflammatory drugs. The antiviral, Remdesivir has been shown to decrease recovery time in patients with COVID-19. The drug chosen to be used with Remdesivir is Baricitinib (Olumiant) which is a proven anti-inflammatory […]